Skip to Main Content
Health Science Information Consortium
LibGuides
The Regional Municipality of York
York Region COVID-19 Guidance
Vaccination Planning
Search this Guide
Search
York Region COVID-19 Guidance
An online repository of guidance documents relevant to COVID-19 for use of York Region Public Health
Home
Ontario Ministry Guidance
IOB resources
General
Acute Care
Assessment/Assessment Clinics
Communications
Community Care / Transmission
Toggle Dropdown
Pharmacies
COVID-19 Variants
Dental Care
Diagnosis
Epidemiology
Toggle Dropdown
Surveillance
Transmission
Forecasting
Seasonality
Ethics
Farms & Migrant Workers
Food Premises
Toggle Dropdown
Food Safety
Health Care Workers
Health Emergency Planning
Toggle Dropdown
Paramedics
Home Care
Infodemics
IPAC Measures
Toggle Dropdown
PPE
Infection Control
Disinfection
Face Masks
Laboratories
Toggle Dropdown
Testing and Results Specifications
Long Covid
Long Term Care Homes
Mass Gatherings
Toggle Dropdown
Religious Services
Mental Health
Palliative Care
Pets
Post Exposure
Toggle Dropdown
Self-Monitoring
Quarantine
Post-Pandemic Planning
Postmortem Guidance
Prisons
Public Health
Schools
Toggle Dropdown
Childcare
Postsecondary
Treatment
Vaccination Planning
Vaccine Safety
Vulnerable Populations
Toggle Dropdown
Addictions
Children
Chronic Conditions
Health Equity
Homelessness
ImmunoCompromised Conditions
Pregnancy
Seniors
Women
Water and Wastewater
Workplaces
VACCINE PROFILES
Ministry of Health. Information Sheet Pfizer-BioNTech and Moderna COVID-19 Vaccines
Government of Canada. Recommendations on the use of COVID-19 vaccines [Mar 1, 2021]
Government of Canada. Moderna COVID-19 vaccine: What you should know
Government of Canada. Pfizer-BioNTech COVID-19 vaccine: What you should know
Government of Canada. AstraZeneca COVID-19 vaccine: What you should know
Government of Canada. Janssen COVID-19 vaccine: What you should know
CANADIAN
Ontario Ministry of Health
Administration of AstraZeneca COVID-19 Vaccine/COVISHIELD Vaccine [v.2.0, Apr 15, 2021]
Administration of Pfizer-BioNTech COVID-19 Vaccine[ [v.5.0, May 28th, 2021]
After Your COVID-19 Vaccine [v.3.1 Jan 11 2022]
COVID-19 Guidance for Individuals Vaccinated outside of Ontario/Canada [V4.0 Mar 24 2022]
COVID-19 Vaccination Recommendations for Special Populations [MOH V9.1 Dec 31 2021]
COVID-19 Vaccination Update-technical briefing v.2 (Feb 2, 2021)
COVID-19 Vaccine Administration Errors and Deviations Guidance [V3.0 Mar 24 2022]
COVID-19 Vaccine Administration [V5 Apr 29 2022]
COVID-19 Vaccine After Care Sheet v.2.0 [amended Jan 6, 2021]
COVID-19 Vaccine Approval Process and Safety [v.3.0, Mar 11, 2021]
COVID-19 Vaccine Availability and Rollout [v.2.0, amended Jan 6, 2021]
COVID-19 Vaccine Clinic Operations Planning Checklist [V 3.0 Mar 11 2021]
COVID-19 Vaccine Consent Form [V 5.0 Dec 31 2021]
COVID-19 Vaccine Information Sheet (age 12+) [V3.0 Mar 24 2022]
COVID-19 Vaccine Surveillance Plan [May 2021]
COVID-19 Vaccine Booster Recommendations [V8.1 May 2 2022]
COVID-19 Vaccine Update. Technical Briefing. The last mile [MOH, Sept 14, 2021]
Vaccine Storage and Handling Guidance [MOH V2.0 Aug 11 2023]
COVID-19 Vaccines for Children and Youth [MOH Nov 22 2021]
Extension of the Second Dose Interval [Mar 19, 2021]
Guidance for COVID-19 Immunization In Long-Term Care Homes and Retirement Homes v.1.0 [Jan 18, 2021]
Guidance for Prioritization of Phase 2 Populations for COVID-19 Vaccination [v.1.1, Mar 23, 2021]
Guidance for Prioritizing Health Care Workers for COVID-19 Vaccination [v.3.0. Mar 17, 2021]
Guidance for Routine Immunization Services during COVID-19 [V 3 May 2022]
Janssen COVID-19 Vaccine Information Sheet [V 1.0 Dec 2 2021]
Medical Exemptions to COVID-19 Vaccination [V 3.0 Jan 12 2022]
Ministry of Health. COVID-19 Vaccine Series Second Dose Eligibility Quick Reference [v.3.0, Jul 6, 2021]
Ontario COVID-19 Vaccine Distribution Plan. Moving to Phase Two in the Plan (Mar 5, 2021)
Sample Statement of Medical Exemption COVID-19 Immunization- Public Use
Staying Up to Date with COVID-19 Vaccines: Recommended Doses [V2 May 2 2022]
Vaccine Clinical Advisory Group (VCAG) Recommendations on Exceptions to Extended Dose Intervals for COVID-19 vaccines [Mar 26, 2021]
Vaccine Storage and Handling Guidelines
What you need to know about your COVID-19 vaccine appointment [v.2.0, Mar 29, 2021]
What you should know about the COVID-19 vaccines [Jan 29, 2021]
National Advisory Committee on Immunization (NACI)
National Advisory Committee on Immunization (NACI): Statements and publications
Summary of national Advisory Committee on Immunization (NACI) Statement of July 11 2023: Guidance on the use of COVID-19 vaccines in the fall of 2023 [NACI Jul 11 2023]
Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19 [NACI Mar 3 2023]
COVID-19 vaccine: Canadian Immunization Guide for health professionals [Last updated Feb 2 2023]
Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023 [NACI Jan 20 2023]
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration [NACI Dec 9 2022]
Public Health Agency of Canada
Adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine [PHAC Mar 16, 2021]
Closing the Gap for Vaccine Hesitancy during the Last Mile of Vaccine Rollout [Sep 13 2021]
Emerging Evidence on COVID-19 Evergreen Rapid Review on COVID-19 Vaccine Attitudes and Uptake – Update 8 [Jul 14 2021]
Emerging Evidence on COVID-19 Evidence Brief on Attitudes and Acceptance of COVID-19 Booster Doses [Jan 2022]
Interim guidance on continuity of immunization programs during the COVID-19 pandemic (2020)
PHAC InfoBulletin on VITT for Health Care Providers [Apr 13, 2021]
Public Health Ontario
ENHANCED EPIDEMIOLOGICAL SUMMARY Neighbourhood COVID-19 Incidence and Vaccination Rates, October 17, 2021 to December 4, 2021 [Jan 14 2022]
ENVIRONMENTAL SCAN COVID-19 Immunity Status and Community Public Health Measures [Apr 29, 2021]
ENVIRONMENTAL SCAN COVID-19 Vaccine Communication Strategies for Community Congregate Living Settings [Mar 26, 2021]
EVIDENCE BRIEF Considerations for Public Health Measures for Individuals with Partial Vaccination for SARS-CoV-2 [Apr 2021]
EVIDENCE BRIEF Risk of COVID-19 Transmission from Vaccinated Cases [June 2021]
FOCUS ON COVID-19 Vaccines: mRNA Vaccines [Mar 2021]
FOCUS ON COVID-19 Vaccines: Viral Vector-based Vaccines [2nd revision Sep 2021]
Impact of Vaccination on Post-Acute COVID-19 Syndrome (PACS) – What We Know So Far [Mar 2022]
Learning Exchange: COVID-19 Vaccine Uptake and Equity Considerations
PRIMER. Building Confidence in Vaccines [2021]
Public Health Measures, Vaccination Programs and Epidemiological Context: An Updated Scan of European Jurisdictions
An overview on current status of public health measures, vaccination programs and epidemiology in select European jurisdictions.
Recommendations: Pfizer-BioNTech COVID-19 Vaccine for Children 5 to 11 Years of Age [Nov 30 2021]
Recommendations: Third COVID-19 Vaccine Dose for Individuals Receiving Dialysis (as part of an extended primary series) [Nov 23 2021]
Recommendations: Fourth COVID-19 Vaccine Dose for Long-Term Care Home Residents and Older Adults in Other Congregate Settings [Dec 29 2021]
Recommendations: Co-Administration of COVID-19 Vaccines in Children 5-11 Years [Apr 29 2022]
SURVEILLANCE REPORT COVID-19 Vaccination Coverage in Ontario by Neighbourhood Diversity and Material Deprivation: December 14, 2020 to August 14, 2022
SURVEILLANCE REPORT COVID-19 Vaccine Uptake in Ontario: December 14, 2020 to August 1, 2022
SYNOPSIS Review of “Evaluation of the BNT162b2 Covid19 Vaccine in Children 5 to 11 Years of Age” [Nov 10 2021]
SYNTHESIS COVID-19 Real-World Vaccine Effectiveness – What We Know So Far [Aug 25 2021]
Synthesis COVID-19 Vaccination for Post-Exposure Prophylaxis (PEP) or Ring Vac [Jun 29 2021]cination – What We Know So Far
SYNTHESIS COVID-19 Vaccine Effectiveness Over Time - What We Know So Far [Oct 28 2021]
SYNTHESIS SARS-CoV-2 Infections after Vaccination – What We Know So Far [July 5 2021]
Vaccination contre la COVID-19 chez les jeunes âgés de 5 à 11 ans au Québec [INSPQ Nov 24 2021]
Vaccine Safety and Surveillance of Adverse Events Following Immunization in Ontario (PPT)
Other
Behavioural Science-Informed Strategies for Increasing COVID-19 Vaccine Uptake in Children and Youth {Science Table V1 Oct 26 2021]
Canadians' willingness to get a COVID-19 vaccine (Study) [StatsCan Jul 7 2020]
COVID-19: Vaccines [CEP 2022]
COVID-19 Advisory Table. Strategies to Support Ontarians’ Capability, Opportunity, and Motivation for COVID-19 Vaccination [June 23, 2021]
COVID-19 Moderna Vaccine Shipping, Storage, Thawing and Use Guidelines [BC CDC Jan 6 2022]
COVID-19 Moderna Vaccine Redistribution Guidelines [BC CDC Jan 6 2022]
COVID-19 Vaccine Confidence in Ontario and Strategies to Support Capability, Opportunity, and Motivation Among at Risk Populations [Science Table V1.0 Oct 8 2021]
COVID-19 Vaccine Eligibility [BC CDC Jan 14 2022]
COVID-19 Vaccine Hesitance: Conversations with Primary Care (Webcast) [NCCID Jul 22 2021]
Factors affecting COVID-19 vaccination acceptance and uptake among the general public: a living behavioural science evidence synthesis [COVID-END V 5 Aug 31 2021]
Guidance Document on the Management of Inadvertent Vaccine Errors [BC CDC Dec 7 2021]
Highlights from the Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization [WHO Oct 2021]
I've taken the vaccine. Now What? (recorded webinar) [RSC Jun 2 2021]
The impact of vaccination status on importation of COVID-19 among international travellers [CCDR Nov 2021]
INFORMATION SESSION ON COVID-19 VACCINATIONS FOR CHILDREN 5-11 [Children’s COVID-19 Vaccine Advisory Table Nov 26 2021]
Is there evidence that children under 18 should receive the booster? [SHA COVID-19 Evidence Support Team Jan 13 2022]
Job Aid for COVID-19 Vaccine Administration [WHO Oct 4 2021]
Likelihood of Transmission of COVID-19 infection after COVID-19 Vaccination [AHS, COVID-19 Scientific Advisory Group Evidence Summary and Recommendations updated Oct 20 2021]
Mandatory COVID-19 vaccination polies for health care workers (Evidence Synthesis Briefing Note). [RAEB Aug 13 2021]
RAPID REVIEW OF THE EVIDENCE ON A COVID-19 BOOSTER DOSE AFTER A PRIMARY VACCINATION SCHEDULE [Dutch Task Force Vaccination Aug 17 2021]
Rapid Review Report: How effective are COVID-19 vaccines? [Saskatchewan Health Authority Nov 26 2021]
Rapid Review Report: What is the epidemiology of variants and what are the implications for healthcare? [SHA Nov 23 2021]
Rapid Review Report: What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns? [Saskatchewan Health Authority Aug 18 2021]
What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy? [SHA COVID-19 Evidence Support Team Aug 17 2021]
An uneven recovery: Measuring COVID-19 vaccine equity in Ontario [Wellesley Institute. Apr 2021]
Medical Exemptions for COVID-19 Vaccine: Jurisdictional Scan [AHS COVID-19 SAG Rapid Brief, Sep 7 2021]
PUBLIC HEALTH UNITS
York Region Public Health
COVID-19 Vaccination Coverage & Herd Immunity- Summary Statement [May 5, 2021]
Vaccination Information for Healthcare Professionals
Guidance for Immunization Priorities During COVID-19 Update to York Region health care providers as of April 24, 2020
Guidance for Vaccine Storage and Handling during COVID-19 Update to York Region health care providers as of April 30, 2020
Pfizer COVID-19 Vaccine for Children [Mar 31st, 2021]
Summary of the Johnson & Johnson/Janssen COVID-19 Vaccine (March 5, 2021)
York Region's COVID-19 Vaccination Plan
Other Health Units
Toronto Public Health.Playbook for the COVID-19 Vaccination Program v.1.2 [updated Mar 9, 2021]
Peel Region. Overview Peel’s Community Mass Vaccination Plan (MVP) [Feb 25, 2021]
INTERNATIONAL
Centers for Disease Control and Prevention (CDC)
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 [MMWR Nov 12 2021]
The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021 [MMWR Nov 5 2021]
APPENDIX B The COVID-19 Vaccine Confidence Conversation Starter
Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 [MMWR Dec 17 2021]
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 [MMWR Sep 24 2021]
Vaccines for COVID-19 [CDC, last updated Jul 13 2023]
COVID-19 Vaccine Equity for Racial and Ethnic Minority Groups [Nov 2 2021]
COVID-19 Vaccines for Moderately or Severely Immunocompromised People [Updated Mar 24 2022]
COVID-19 Vaccines While Pregnant or Breastfeeding [Updated Nov 8 2021]
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 [MMWR Nov 5 2021]
How to Build Healthcare Personnel’s Confidence in COVID-19 Vaccines
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021 [MMWR Dec 31 2021]
Stay Up to Date with Your Vaccines [Jan 16 2022]
Resources to Promote the COVID-19 Vaccine for Children & Teens [last updated Nov 16 2021]
Science Brief: COVID-19 Vaccines and Vaccination [Updated Sep 15 2021]
Science Brief: SARS-CoV-2 Infection-induced and Vaccine-induced Immunity [2021]
U.S. COVID-19 Vaccine Product Information
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021 [MMWR Sep 24 2021]
Vaccinate with Confidence COVID-19 Vaccines Strategy
Vaccine Storage and Handling Toolkit CS296544-B March 2021 Updated with COVID-19 Vaccine Storage and Handling Information Addendum added Sept 29, 2021
Public Health England
Department of Health & Social Care. UK COVID-19 vaccines delivery plan [Jan 2021]
Guidance COVID-19 vaccination: booster dose resources [Feb 2 2022]
World Health Organization
An update on COVID-19 vaccine booster doses [WHO Sep 3 2021]
Good practice statement on the use of second booster doses for COVID-19 vaccines [Aug 18 2022]
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19 [Aug 2022]
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 [Aug 2022]
COVAX facility: Global procurement for COVID-19 Vaccines (Aug 6 2020)
COVID-19 immunization in refugees and migrants: principles and key considerations. Interim Guidance. [WHO Aug 31 2021]
Criteria for COVID-19 vaccine prioritization [WHO May 17 2020]
Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons: Interim guidance [WHO Oct 26 2021]
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 [Updated Aug 18 2022]
Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing [Updated Aug 18 2022]
Interim statement on booster doses for COVID-19 vaccination [update Oct 4 2021]
Interim statement on COVID-19 vaccination for children and adolescents [Nov 24 2021]
Framework for decision-making: implementation of mass vaccination campaigns in the context of COVID-19
Guiding principles for immunization activities during the COVID-19 pandemic (Mar 26)
Immunization in the context of COVID-19 pandemic: Frequently Asked Questions (Apr 16)
The Oxford/AstraZeneca COVID-19 vaccine: what you need to know [WHO Sep 2 2021]
PAHO: The Immunization Program in the Context of the COVID-19 Pandemic (Mar 26)
OTHER
John Hopkins. Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States
Comirnaty and Spikevax: EMA recommendations on extra doses and boosters [EMA Oct 4 2021]
COVID-19 Vaccination: An equitable response [APHA ]
Evaluation of a Booster Dose (Third Dose) [Vaccines and related biological products advisory committee briefing document Sep 17 2021]
Facilitating COVID-19 vaccination acceptance and uptake in the EU/EEA [ECDC Oct 15 2021]
In brief Public health measures and COVID-19 vaccine rollout [COVID-19 Critical Intelligence Unit Sep 30 2021]
In brief COVID-19 vaccine booster shots [NSW Government Oct 12 2021]
In brief COVID-19 vaccines in Australia [NSW, Agency for Clinical Innovation Oct 14 2021]
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance—Nine States, June–August 2021
Interim public health considerations for COVID-19 vaccination of children aged 5-11 years [ECDC Dec 1 2021]
Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA [ECDC Nov 11 2021]
Measuring vaccine efficacy from population data [CEBM Oct 25 2021]
Report 48: The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant [Imperial College COVID-19 Response Team Dec 16 2021]
Video: Five C's to boost COVID-19 vaccination [ECDC Nov 9 2021]
NSW Health Australia. Critical Intelligence Unit. What evidence is emerging about the efficacy, safety and rollout of COVID-19 vaccines? [Feb 5, 2021]
FDA Briefing Document. Moderna COVID-19 Vaccine [Dec 2020]
Health Information and Quality Authority. An international review: Policies relating to healthcare personnel who do not avail of COVID-19 vaccination [updated Apr 20, 2021]
Health Information Quality Authority. Protocol. Policies relating to healthcare personnel who do not avail of COVID-19 vaccination: an international review
<<
Previous:
Treatment
Next:
Vaccine Safety >>